IRIS Accounts Production v24.1.0.578 13070446 director 1.1.23 31.12.23 31.12.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh130704462022-12-31130704462023-12-31130704462023-01-012023-12-31130704462021-12-31130704462022-01-012022-12-31130704462022-12-3113070446ns15:EnglandWales2023-01-012023-12-3113070446ns14:PoundSterling2023-01-012023-12-3113070446ns10:Director12023-01-012023-12-3113070446ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3113070446ns10:SmallEntities2023-01-012023-12-3113070446ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3113070446ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3113070446ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3113070446ns10:AbridgedAccounts2023-01-012023-12-3113070446ns10:RegisteredOffice2023-01-012023-12-3113070446ns5:CurrentFinancialInstruments2023-12-3113070446ns5:CurrentFinancialInstruments2022-12-3113070446ns5:ShareCapital2023-12-3113070446ns5:ShareCapital2022-12-3113070446ns5:RetainedEarningsAccumulatedLosses2023-12-3113070446ns5:RetainedEarningsAccumulatedLosses2022-12-3113070446ns5:PlantMachinery2023-01-012023-12-31
REGISTERED NUMBER: 13070446 (England and Wales)















Financial Statements for the Year Ended 31 December 2023

for

Imperial Life Sciences Ltd

Imperial Life Sciences Ltd (Registered number: 13070446)






Contents of the Financial Statements
for the Year Ended 31 December 2023




Page

Company Information 1

Abridged Statement of Financial Position 2

Notes to the Financial Statements 3


Imperial Life Sciences Ltd

Company Information
for the Year Ended 31 December 2023







DIRECTOR: N D Brown





REGISTERED OFFICE: 79 Milbank Road
Darlington
Co. Durham
DL3 9NN





REGISTERED NUMBER: 13070446 (England and Wales)





ACCOUNTANTS: Chrichard & Co
23 Woodland Road
Darlington
Co. Durham
DL3 7BJ

Imperial Life Sciences Ltd (Registered number: 13070446)

Abridged Statement of Financial Position
31 December 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,837 1,288

CURRENT ASSETS
Debtors 23,001 16,119
Cash at bank 40,741 12,435
63,742 28,554
CREDITORS
Amounts falling due within one year 54,294 25,998
NET CURRENT ASSETS 9,448 2,556
TOTAL ASSETS LESS CURRENT
LIABILITIES

11,285

3,844

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 11,284 3,843
SHAREHOLDERS' FUNDS 11,285 3,844

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Statement of Financial Position for the year ended 31 December 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 22 March 2024 and were signed by:




N D Brown - Director


Imperial Life Sciences Ltd (Registered number: 13070446)

Notes to the Financial Statements
for the Year Ended 31 December 2023

1. STATUTORY INFORMATION

Imperial Life Sciences Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 15% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

Imperial Life Sciences Ltd (Registered number: 13070446)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2023

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 January 2023 1,800
Additions 1,206
At 31 December 2023 3,006
DEPRECIATION
At 1 January 2023 512
Charge for year 657
At 31 December 2023 1,169
NET BOOK VALUE
At 31 December 2023 1,837
At 31 December 2022 1,288